ClinicalTrials.Veeva

Menu

Enhanced Recovery After Cesarean Section With Low Dose Intrathecal Morphine.

M

Minia University

Status

Unknown

Conditions

Vomiting, Postoperative
Pain, Postoperative
Nausea, Postoperative
Pruritus

Treatments

Drug: Bupivacaine Hydrochloride
Drug: Morphine Sulfate

Study type

Interventional

Funder types

Other

Identifiers

NCT04618146
680-9\2020

Details and patient eligibility

About

This study is designed to see the effect of low dose intrathecal morphine on promting enhanced recovery after cesarean delivery with early ambulation and reduction of hospital stay.

Full description

Parturients showing for elective cesarean section will be randomized into 3 groups by a computer generated randomization list. Each randomization slip will be put in a sealed envelope until patient enrollment. Patients will be divided into Group C: control group, given intrathecal bupivacaine 12.5 mg. Group M25: intrathecal bupivacaine 12.5mg + morphine 25 microgram. Group M50: intrathecal bupivacaine 12.5mg + morphine 50 microgram.

Enrollment

60 estimated patients

Sex

Female

Ages

16 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Females scheduled for cesarean section
  • Age: 16-45 yrs.
  • Gestation age >38 weeks.
  • ASA I,II

Exclusion criteria

  • Refusal to participate.
  • Significant cardiac, hepatic or renal dysfunction.
  • History of chronic itching problem, or hyperemesis during pregnancy

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 3 patient groups, including a placebo group

Group C
Placebo Comparator group
Description:
given intrathecal bupivacaine 12.5 mg.
Treatment:
Drug: Bupivacaine Hydrochloride
Group M25
Active Comparator group
Description:
given intrathecal bupivacaine 12.5mg + morphine 25 microgram.
Treatment:
Drug: Morphine Sulfate
Drug: Bupivacaine Hydrochloride
Group M50
Active Comparator group
Description:
given intrathecal bupivacaine 12.5mg + morphine 50 microgram.
Treatment:
Drug: Morphine Sulfate
Drug: Bupivacaine Hydrochloride

Trial contacts and locations

1

Loading...

Central trial contact

Sohair A Megalla, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems